Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Health Catalyst Inc (NASDAQ: HCAT) closed at $7.08 in the last session, down -0.14% from day before closing price of $7.09. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 0.56 million shares were traded. HCAT stock price reached its highest trading level at $7.2 during the session, while it also had its lowest trading level at $6.775.
Ratios:
We take a closer look at HCAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 1.03 whereas as Long-Term Debt/Eq ratio is at 0.37.
On January 03, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $11.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $14.Barclays initiated its Overweight rating on January 03, 2024, with a $14 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 23 ’24 when Gallagher Duncan sold 4,500 shares for $6.98 per share. The transaction valued at 31,415 led to the insider holds 74,438 shares of the business.
DUNCAN GALLAGHER bought 4,500 shares of HCAT for $31,905 on Dec 23 ’24. On Dec 16 ’24, another insider, Llewelyn Linda, who serves as the Chief People Officer of the company, sold 6,442 shares for $7.88 each. As a result, the insider received 50,794 and left with 98,702 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 430801696 and an Enterprise Value of 407877408. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.42 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 1.35 whereas that against EBITDA is -12.714.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $11.41, while it has fallen to a 52-week low of $5.42. The 50-Day Moving Average of the stock is -11.40%, while the 200-Day Moving Average is calculated to be -2.18%.
Shares Statistics:
According to the various share statistics, HCAT traded on average about 496.72K shares per day over the past 3-months and 542530 shares per day over the past 10 days. A total of 60.85M shares are outstanding, with a floating share count of 58.48M. Insiders hold about 3.89% of the company’s shares, while institutions hold 87.54% stake in the company. Shares short for HCAT as of 1734048000 were 2555695 with a Short Ratio of 5.15, compared to 1731628800 on 2530154. Therefore, it implies a Short% of Shares Outstanding of 2555695 and a Short% of Float of 4.279999999999999.
